Enterprise AI

    Now Live: The World’s Most Powerful AI Factory for Pharmaceutical Discovery and Development

    Eli Lilly launches LillyPod, the industry's first internally owned NVIDIA DGX SuperPOD for accelerated drug discovery.

    Lilly this week launched the most powerful AI factory wholly owned and operated by a pharmaceutical company to help its teams make meaningful medical advancements faster, more accurately and at unprecedented scale. Dubbed LillyPod, it’s the world’s first NVIDIA DGX SuperPOD with ...

    NB

    NVIDIA Blog

    Source

    NVIDIA Blog
    Now Live: The World’s Most Powerful AI Factory for Pharmaceutical Discovery and Development
    AI Analysis

    Generated insight by OnAirToday AI

    LillyPod marks a pivotal shift toward vertical integration in drug discovery, allowing pharmaceutical giants to bypass third-party bottlenecks. By leveraging dedicated supercomputing infrastructure, the company can compress R&D timelines and optimize molecular screening with unprecedented internal control.

    Powered by AI • Not a substitute for human analysisMore Insights →
    Read the full story at NVIDIA Blog →
    Share
    Filed under:Enterprise AI

    Comments

    Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.

    0/1000